Center for Lawful Access and Abuse Deterrence Company Profile

02:13 EDT 22nd March 2018 | BioPortfolio

News Articles [1247 Associated News Articles listed on BioPortfolio]

US FDA guidance aims to encourage generic abuse-deterrent opioids

The US FDA has issued final guidance for evaluating the abuse deterrence of generic solid oral opioid drug products in efforts to deter abuse.

Pain Therapeutics gains on abuse-deterrence data

Pain Therapeutics reports abuse-deterrence data for Remoxy ER

Generic Abuse-Deterrent Opioids: Comparison To Brand Will Not Require Use Of Control

FDA final guidance recommends comparative pharmacodynamic studies for nasal and oral routes of abuse, simplifies statistical approach to show deterrence...   

Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO® ER (morphine sulfate) ...

ARYMO ER, developed using Egalet's proprietary Guardian™ Technology—a physical and chemical barrier approach to abuse deterrence without the use of an opioid antagonist—creating tablets that ...

Prescription Drug Abuse Increasingly Seen as a Major U.S. Public Health Problem

(Pew Research Center) – Americans’ concerns about prescription drug abuse have risen over the past four years, with some of largest increases coming among well-educated adults. Today, 76% of t...

The Story of the Turpin Family at Center of Abuse Allegations

David and Louise Turpin pleaded not guilty to a combined 75 counts that included charges of torture, child abuse and false imprisonment.

Not Your Typical Response: Oxycodone Sponsor Seeks FDA Hearing On Complete Response Letter

Data on abuse deterrence for Pharmaceutical Manufacturing Research Services' oxycodone immediate-release product are insufficient, FDA tells company.   

Drugs and Medications [76 Associated Drugs and Medications listed on BioPortfolio]

Formucare triple antibiotic [Access Business Group International LLC]

Access Business Group International LLC Triple Antibiotic Drug Facts

Fulton street market athletes foot [Access Business Group LLC]

Access Business Group LLC Athlete's Foot Cream Drug Facts

Formucare ranitidine [Access Business Group International LLC]

Access Business Group International LLC Ranitidine 75 Drug Facts

Glister multi-action fluoride toothpaste [Access Business Group, LLC]

Glister Multi-action Fluoride Toothpaste

Formucare athletes foot [Access Business Group International LLC]

Access Business Group International LLC Athlete's Foot Powder Spray Drug Facts

PubMed Articles [1725 Associated PubMed Articles listed on BioPortfolio]

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.

To assess the intranasal abuse potential of hydrocodone extended-release (ER) tablets developed with CIMA Abuse-Deterrence Technology compared with hydrocodone powder and hydrocodone bitartrate ER cap...

The barriers to a national inquiry into child sexual abuse in the United States.

There is an often-overlooked but critical factor at the center of institutional child sexual abuse that must be acknowledged and addressed: adults tend to place the interest of institutions and other ...

The Risk of Assuming Abuse in an Infant with an Isolated Metaphyseal Lesion: A Case Report.

The classic metaphyseal lesion, or corner fracture, is considered a strong indicator of nonaccidental trauma. In the present case, the parents brought their 8-month-old boy to a community hospital aft...

Outcomes of three types of native arteriovenous fistula in a single center.

To study the outcomes of three different types of native arteriovenous fistula (AVF), the distal (D: radial-cephalic), middle-arm (MA: radial-cephalic) and proximal (P: brachial-cephalic) AVF access c...

Prins Reaction of Homoallenyl Alcohols: Access to Substituted Pyrans in the Halichondrin Series.

Prins reaction of homoallenyl alcohols with aldehyde dimethylacetals in the presence of methoxyacetic acid directly affords tetrasubstituted pyrans relevant to halichondrins with complete control of t...

Clinical Trials [3453 Associated Clinical Trials listed on BioPortfolio]

Telephone Intervention to Increase Safety in Abused Women

Although abuse by an intimate partner is very common and has serious negative effects on women's health, few studies have been done to test ways to increase safety for women in abusive rel...

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

The purpose of this study is to determine the relative abuse potential of ramelteon, once daily (QD), compared to triazolam in subjects with a history of drug abuse.

Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse

The purpose of this study is: (1) to assess the effect of oxycodone HCl on niacin-induced dysphoric effects when oxycodone HCl is administered in combination with niacin in subjects with a...

Exploration of the Potential Role of Brain Magnetic Stimulation in Preventing Relapse to Alcohol Abuse

dTMS intervention to reduce recurrent alcohol abuse among alcohol users who are abstinent for at least two weeks.

Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment

The initial phase of substance abuse treatment is a vulnerable period for relapse. Cognitive impairments are common during this phase and may reduce the ability to benefit from other forms...

Companies [2334 Associated Companies listed on BioPortfolio]

Center for Lawful Access and Abuse Deterrence

Tris Pharma

Tris Pharma is a product-focused, specialty pharmaceutical company engaged in the research and development of innovative drug delivery technologies. Through its OralXR+ platform, Tris has pioneered th...

Prescription Drug Research Center

The Prescription Drug Research Center is located at the Mason Enterprise Center, a part of George Mason University, in Fairfax, Virginia. As a member of the Mason Enterprise Center, PDRC enjoys access...

Didi Hirsch Mental Health Services

With almost 70 years of experience, Didi Hirsch provides mental health and substance abuse services at ten sites in Los Angeles and Orange County. A member of the National Suicide...

Gatekeeper Innovation, Inc.

Gatekeeper Innovation saves lives endangered by prescription drug abuse. The company makes affordable products that reduce prescription abuse potential and, in doing so, ch...

More Information about "Center for Lawful Access and Abuse Deterrence" on BioPortfolio

We have published hundreds of Center for Lawful Access and Abuse Deterrence news stories on BioPortfolio along with dozens of Center for Lawful Access and Abuse Deterrence Clinical Trials and PubMed Articles about Center for Lawful Access and Abuse Deterrence for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Center for Lawful Access and Abuse Deterrence Companies in our database. You can also find out about relevant Center for Lawful Access and Abuse Deterrence Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record